Ignite Creation Date:
2024-10-25 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06549413
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-08
Brief Title:
18F-FSPG PETCT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
18F-FSPG PETCT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to learn how 18F-FSPG PETCT scan results may be related to the response to chemotherapy and radiation in patients with esophageal cancer
Detailed Description:
PRIMARY OBJECTIVES
I Evaluate the ability of 18F-FSPG PET imaging to detect tumors in patients with esophageal cancer
I Evaluate the ability of 18F-FSPG PET imaging to detect tumors in patients with esophageal cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None